Lung cancer is the second most commonly diagnosed cancer in both men and women, and the most prevalent cause of cancer death in the United States. A comprehensive array of diagnoses and treatment options, including minimally invasive, robotic-assisted surgery and access to clinical trials, are important considerations for patients in general.
Advances in diagnostic imaging and biomedical research continue to evolve rapidly and it will continue to affect screening and therapeutic procedures and programs. Cost-benefit analysis and public policy implications for coverage and reimbursement will also play a significant role in these.
Conference Chairperson
Andrea Borondy Kitts
MS, MPH, Patient Outreach and Research Specialist
Lahey Hospital and Medical Center
Juan Carlos Batlle
MD, MBA, Chief of Thoracic Imaging, Associate Professor, FIU – School of Medicine
Baptist Health South Florida
Andrew Salner
MD, FACR, Medical Director
Hartford Healthcare Cancer Institute and Hartford Hospital
Andrea Borondy Kitts
MS, MPH, Patient Outreach and Research Specialist
Lahey Hospital and Medical Center
Kathryn Taylor
PhD, Professor, Department of Oncology, Cancer Prevention and Control Program
Lombardi Comprehensive Cancer Center
Georgetown University Medical Center
Gabriela Dieguez
Principal and Consulting Actuary
Milliman
Matthew Schabath
PhD, Associate Member, Department of Cancer Epidemiology
Moffitt Cancer Center
April Plank
DNP, Co-Director
The Center for Lung Cancer Screening and Prevention at Stony Brook University Cancer Center
Ana Ruiz
Manager, Cancer Program
Mount Sinai Medical Center
Estelamari Rodriguez
MD, Medical Director Thoracic Oncology, Chair, Women’s Centered Care Network
Mount Sinai Medical Center
Dr. Roy F. Williams
Director Thoracic Surgery
Mount Sinai Medical Center
Brett Schussel
MSN, FNP-BC, Nurse Practitioner Director of Lung Cancer Screening Program
UCLA Medical Center
Robert C. Gilkeson
MD, Vice Chairman of Research, Department of Radiology
University Hospitals – UH Case Medical Center
Katherine Y. Tossas-Milligan
PhD, MS, Director, Office of Global Assets and Innovative Approaches (GAIA) to Cancer Equity
University of Illinois Cancer Center
Robert A. Winn
MD, Director of the UI Health Cancer Center and Associate Vice Chancellor of Community Based Practice
University of Illinois Hospital and Health Sciences System
Rafael Meza
Associate Professor, Co-Leader, Departmen of Cancer Epidemiology and Prevention Program – School of Public Health
University of Michigan Comprehensive Cancer Center
Brendon Stiles
MD, Associate Professor, Department of Cardiothoracic Surgery
Weill Cornell Medical College
New York Presbyterian Hospital
This two-day conference will offer excellent opportunities for you to network with your peers: CEOs, CIOs, CSOs, Vice-Presidents, Directors, and Senior Managers responsible for
Key titles include:
We are all about lung cancer. We’re about compassion and education. We’re about encouragement and hope. We’re about community. We’re about making the world better for people facing this disease. We’re reaching out and we hope you will take our hand to receive strength from us…or give us strength. Lung cancer is a difficult topic. Most think they know about it. Few do…until they are personally touched by it. Find out more about us, about lung cancer and what you can do to fight it here.
Website: www.dustyjoy.org
Free ME from Lung Cancer is the only nonprofit based in Maine dedicated solely to raising money for lung cancer research, providing low dose CT scans to high risk under insured or uninsured patients and prevention. It is our goal to reduce the suffering caused by this disease in our lifetime.
Website: www.freemefromlungcancer.org
OUR MISSION is to ensure surviving lung cancer is the expectation, not the exception. OUR VISION: Double lung cancer survival by 2022. To turn this vision into reality, we focus on funding research with the greatest potential to save lives, increasing the number of lung cancer patients participating in clinical trials, and building and empowering the lung cancer community Join us on our journey to double lung cancer survival by 2022!
Website: www.freetobreathe.org
If you would like a copy of the brochure for this conference please complete the form below and click 'submit'.
3 people are attending 6th Lung Cancer Screening & Continuum of Care